1990—2021年中国14岁以下儿童下呼吸道感染发病和死亡趋势与预测及病原学特征分析

廖云, 林映映, 李燕羽, 杨京华

中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (4) : 470-479.

PDF(2412 KB)
HTML
PDF(2412 KB)
HTML
中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (4) : 470-479. DOI: 10.7499/j.issn.1008-8830.2503163
论著·临床研究

1990—2021年中国14岁以下儿童下呼吸道感染发病和死亡趋势与预测及病原学特征分析

作者信息 +

Trends, predictions, and etiological characteristics of the incidence and mortality of lower respiratory infections among children under 14 years in China from 1990 to 2021

Author information +
文章历史 +

摘要

目的 分析1990—2021年我国儿童下呼吸道感染(lower respiratory infection, LRI)发病和死亡的变化趋势与未来预测,并比较不同年龄段儿童的病原学特征。 方法 基于全球疾病负担数据库,收集1990—2021年中国儿童LRI的流行病学数据,对比分析我国、全球以及高社会人口指数(socio-demographic index, SDI)地区儿童LRI的流行趋势及未来预测,并探讨不同病原体对我国儿童LRI的影响等。 结果 1990—2021年,我国儿童LRI疾病负担低于全球平均水平,但仍高于高SDI地区。我国儿童LRI发病率和死亡率呈显著下降趋势,其中5岁以下儿童的降幅最明显,而10~14岁LRI发病率降幅低于全球水平。预测显示,2022—2040年我国儿童LRI发病率和死亡率将持续下降。细菌仍是我国儿童LRI的最主要病原体。不同年龄组的病原谱构成存在显著差异,5岁以下儿童的病毒性LRI疾病负担高于5~14岁儿童,而非典型病原体的疾病负担则低于5~14岁儿童。 结论 1990—2021年我国儿童LRI负担总体呈下降趋势,且预计未来将持续下降。10~14岁儿童LRI发病率的降幅落后于全球水平,提示该年龄群体在防控中尚存在薄弱环节。儿童各年龄段的致病谱构成不同,建议针对不同年龄群体实施精准化的干预策略,并持续进行病原谱的动态监测。

Abstract

Objective To analyze trends and future projections of lower respiratory infection (LRI) incidence and mortality among children in China from 1990 to 2021, and to compare etiological characteristics across age groups. Methods Epidemiological data for pediatric LRI in China from 1990 to 2021 were obtained from the Global Burden of Disease database. Comparative analyses examined trends and projections for China, the global population, and high socio-demographic index (SDI) regions. The influence of different pathogens on pediatric LRI in China was also assessed. Results From 1990 to 2021, the burden of LRI among children in China was lower than the global average but higher than that in high-SDI regions. Incidence and mortality rates showed a significant downward trend, with the most pronounced decline in children under 5 years of age, while the decline in LRI incidence among those aged 10-14 years was slower than the global level for the same age group. Projections for 2022-2040 indicated continued decreases in incidence and mortality of pediatric LRI in China. Bacterial infections remained the predominant cause of pediatric LRI in China. Marked age-specific differences in pathogen spectra were observed: viral LRI burden was higher in children under 5 years than in those aged 5-14 years, whereas the burden due to atypical pathogens was lower in children under 5 years than in those aged 5-14 years. Conclusions From 1990 to 2021, the overall burden of pediatric LRI in China shows a declining trend and is predicted to continue to decrease. The slower decline in LRI incidence among children aged 10-14 years compared with the global level indicates a weakness in prevention for this age group. Distinct age-specific pathogen profiles suggest the need for age-targeted interventions and continuous surveillance of pathogen spectra.

关键词

下呼吸道感染 / 疾病负担 / 病原体 / 中国 / 儿童

Key words

Lower respiratory infection / Disease burden / Pathogen / China / Child

引用本文

导出引用
廖云, 林映映, 李燕羽, . 1990—2021年中国14岁以下儿童下呼吸道感染发病和死亡趋势与预测及病原学特征分析[J]. 中国当代儿科杂志. 2026, 28(4): 470-479 https://doi.org/10.7499/j.issn.1008-8830.2503163
Yun LIAO, Ying-Ying LIN, Yan-Yu LI, et al. Trends, predictions, and etiological characteristics of the incidence and mortality of lower respiratory infections among children under 14 years in China from 1990 to 2021[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(4): 470-479 https://doi.org/10.7499/j.issn.1008-8830.2503163

参考文献

[1]
Perin J, Mulick A, Yeung D, et al. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the sustainable development goals[J]. Lancet Child Adolesc Health, 2022, 6(2): 106-115. PMCID: PMC8786667. DOI: 10.1016/S2352-4642(21)00311-4 .
[2]
GBD 2017 Lower Respiratory Infections Collaborators. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017[J]. Lancet Infect Dis, 2020, 20(1): 60-79. PMCID: PMC7185492. DOI: 10.1016/S1473-3099(19)30410-4 .
[3]
GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021[J]. Lancet Infect Dis, 2024, 24(9): 974-1002. PMCID: PMC11339187. DOI: 10.1016/S1473-3099(24)00176-2 .
[4]
Pratt MTG, Abdalla T, Richmond PC, et al. Prevalence of respiratory viruses in community-acquired pneumonia in children: a systematic review and meta-analysis[J]. Lancet Child Adolesc Health, 2022, 6(8): 555-570. DOI: 10.1016/S2352-4642(22)00092-X .
[5]
Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children[J]. N Engl J Med, 2015, 372(9): 835-845. PMCID: PMC4697461. DOI: 10.1056/NEJMoa1405870 .
[6]
Wang Z, Peng Y, Yang S, et al. Risk factors for complications of Mycoplasma pneumoniae pneumonia in hospitalized children in China: a systematic review and meta-analysis[J]. BMC Pediatr, 2024, 24(1): 810. PMCID: PMC11654151. DOI: 10.1186/s12887-024-05279-9 .
[7]
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024, 403(10440): 2133-2161. PMCID: PMC11122111. DOI: 10.1016/S0140-6736(24)00757-8 .
[8]
GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024, 403(10440): 2162-2203. PMCID: PMC11120204. DOI: 10.1016/S0140-6736(24)00933-4 .
[9]
Cen J, Wang Q, Cheng L, et al. Global, regional, and national burden and trends of migraine among women of childbearing age from 1990 to 2021: insights from the Global Burden of Disease Study 2021[J]. J Headache Pain, 2024, 25(1): 96. PMCID: PMC11157953. DOI: 10.1186/s10194-024-01798-z .
[10]
Tuo Y, Li Y, Li Y, et al. Global, regional, and national burden of thalassemia, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. EClinicalMedicine, 2024, 72: 102619. PMCID: PMC11090906. DOI: 10.1016/j.eclinm.2024.102619 .
[11]
赵倩, 许佳敏, 吕军, 等. 中国儿童发展纲要和国民经济发展五年规划: 儿童健康发展变迁分析[J]. 中国公共卫生, 2022, 38(6): 641-646. DOI: 10.11847/zgggws1137426 .
[12]
郝创利, 蒋吴君. COVID-19疫情对儿童呼吸道感染病原流行病学影响[J]. 临床儿科杂志, 2025, 43(3): 163-167. DOI: 10.12372/jcp.2025.24e1156 .
[13]
Xie Y, Lin S, Zeng X, et al. Two peaks of seasonal influenza epidemics: China, 2023[J]. China CDC Wkly, 2024, 6(36): 905-910. PMCID: PMC11425296. DOI: 10.46234/ccdcw2024.069 .
[14]
刘凯, 付红敏, 陆权. 儿童肺炎支原体肺炎的流行病学新进展[J]. 中华儿科杂志, 2024, 62(7): 696-699. DOI: 10.3760/cma.j.cn112140-20240407-00247 .
[15]
疾病预防控制局. 国家卫生健康委关于印发国家免疫规划疫苗儿童免疫程序及说明(2021年版)的通知: 国卫疾控发[2021]10号[EB/OL]. (2021-03-12)[2025-05-09].
[16]
孙伟, 高洁, 马莹, 等. 2009—2018年宁夏流行性感冒流行特征[J]. 中华疾病控制杂志, 2020, 24(6): 691-695. DOI: 10.16462/j.cnki.zhjbkz.2020.06.014 .
[17]
Yang Y, Pan X, Cheng W, et al. Haemophilus influenzae type b carriage and burden of its related diseases in Chinese children: systematic review and meta-analysis[J]. Vaccine, 2017, 35(46): 6275-6282. DOI: 10.1016/j.vaccine.2017.09.057 .
[18]
Shen CF, Wang SM, Chi H, et al. The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia[J]. J Biomed Sci, 2020, 27(1): 88. PMCID: PMC7435222. DOI: 10.1186/s12929-020-00680-9 .
[19]
GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Infect Dis, 2018, 18(11): 1191-1210. PMCID: PMC6202443. DOI: 10.1016/S1473-3099(18)30310-4 .
[20]
Logan LK, Gandra S, Trett A, et al. Acinetobacter baumannii resistance trends in children in the United States, 1999-2012[J]. J Pediatric Infect Dis Soc, 2019, 8(2): 136-142. PMCID: PMC6510944. DOI: 10.1093/jpids/piy018 .
[21]
McLean HQ, Petrie JG, Hanson KE, et al. Interim estimates of 2022-23 seasonal influenza vaccine effectiveness: Wisconsin, October 2022-February 2023[J]. MMWR Morb Mortal Wkly Rep, 2023, 72(8): 201-205. PMCID: PMC9949852. DOI: 10.15585/mmwr.mm7208a1 .
[22]
Walsh PS, Schnadower D, Zhang Y, et al. Association of early oseltamivir with improved outcomes in hospitalized children with influenza, 2007-2020[J]. JAMA Pediatr, 2022, 176(11): e223261. PMCID: PMC9486642. DOI: 10.1001/jamapediatrics.2022.3261 .
[23]
Lai X, Ma Y, Fang H. Better adherence to childhood Haemophilus influenzae type b vaccination with combination vaccines compared to single-antigen vaccines: evidence from China[J]. J Glob Health, 2023, 13: 04080. PMCID: PMC10451103. DOI: 10.7189/jogh.13.04080 .
[24]
Liu L, Zhang Z, Zhang X, et al. Coverage of 13-valent pneumococcal conjugate vaccine among children 0-15 months of age: 9 provinces, China, 2019-2021[J]. China CDC Wkly, 2023, 5(17): 379-384. PMCID: PMC10184383. DOI: 10.46234/ccdcw2023.072 .
[25]
全国细菌耐药监测网. 2018至2022年0~14岁患儿细菌耐药监测研究[J]. 中华儿科杂志, 2023, 61(11): 1001-1010. DOI: 10.3760/cma.j.cn112140-20230710-00445 .
[26]
张东伟, 卢根. 呼吸道病毒感染所致的儿童危重症诊治进展[J]. 中国实用儿科杂志, 2019, 34(2): 111-116. DOI: 10.19538/j.ek2019020612 .
[27]
Wang X, Li Y, Deloria-Knoll M, et al. Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study[J]. Lancet Glob Health, 2021, 9(1): e33-e43. PMCID: PMC7783516. DOI: 10.1016/S2214-109X(20)30393-4 .
[28]
中国疾病预防控制中心. 全国急性呼吸道传染病哨点监测情况(2025年第13周)[EB/OL]. (2025-04-03)[2025-05-09].
[29]
董晓艳, 邹映雪, 吕芳芳, 等. 儿童肺炎支原体肺炎病原检测的多中心临床研究[J]. 中华儿科杂志, 2024, 62(4): 310-316. DOI: 10.3760/cma.j.cn112140-20240117-00054 .
[30]
Zhang Y, Su C, Zhang Y, et al. Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study[J]. BMC Infect Dis, 2025, 25(1): 18. PMCID: PMC11699690. DOI: 10.1186/s12879-024-10370-8 .
[31]
Li ZJ, Zhang HY, Ren LL, et al. Etiological and epidemiological features of acute respiratory infections in China[J]. Nat Commun, 2021, 12(1): 5026. PMCID: PMC8373954. DOI: 10.1038/s41467-021-25120-6 .

脚注

所有作者声明不存在利益冲突。

基金

广东省防控新型冠状病毒感染科技攻关应急专项(2023B1111020004)
广州市科技计划项目(2024A03J0125)
2024广东省名中医传承工作室建设项目-许尤佳(0102018005)
广东省中医急症研究重点实验室项目(2023B1212060062)

版权

版权所有 © 2023中国当代儿科杂志
PDF(2412 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/